Boostaro is a new blood flow support supplement and has received positive feedback and attention from users and experts. The ...

Newsom also offered to help find a mutually agreeable mediator, as he did during the Northern California strike in 2022, when ...

Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) announced that their drug ENHERTU has demonstrated a statistically significant ...

Intensifying oral diuretic therapy was linked to worse prognosis, but not everybody is sold on its use an endpoint.

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...

In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, ...

A clinical trial to test the effectiveness of a new, plant-based oral drug to treat type 2 diabetes has produced some ...

You can fix your eyes, your nose, get injections for crow’s feet, but the neck often gives away your age. As we age, our necks can make us look older. That loose skin around the neck area is ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall ...

Y-mAbs Therapeutics, Inc. (the "Company” or "Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

Psilocybin-assisted psychotherapy significantly improved a range of psychiatric symptoms among people with cancer, according ...